Key result
Daily low-dose aspirin fails to reduce cardiovascular death in primary prevention.
Why the study?
The evidence supporting the use of low-dose aspirin for primary prevention in adults without cardiovascular disease is limited.
Does daily low-dose aspirin prevent cardiovascular disease and death in adults without a history of cardiovascular disease?
Systematic Review
Does daily low-dose aspirin prevent cardiovascular disease and death in adults without a history of cardiovascular disease?
Answers are grounded in this paper and cite their sources.
Daily low-dose aspirin does not lower the risk of death from cardiovascular disease when used for primary prevention in adults without a history of cardiovascular disease.
BACKGROUND: Cardiovascular disease is the leading cause of death in the United States. Patients with cardiovascular disease risk factors are often put on low-dose aspirin to prevent future cardiovascular events and cardiovascular death. However, the evidence supporting this practice is limited. OBJECTIVE: To examine whether adults without a history of cardiovascular disease benefit from taking daily low-dose aspirin as primary prevention for cardiovascular disease and death. DATA SOURCES: The four databases of PubMed, CINAHL, Scopus, and Ovid were used, and a total of 67 nonduplicate articles were reviewed. After examining those articles, four studies were included. Of the four studies, three were randomized controlled trials, and one was a retrospective cohort study. CONCLUSIONS: All four studies concluded that daily low-dose aspirin used for primary prevention does not lower the risk of death from cardiovascular disease. IMPLICATIONS FOR PRACTICE: Further research needs to be conducted to determine whether daily low-dose aspirin is beneficial in individuals without a history of cardiovascular disease. Nurse practitioners need to know the most current evidence-based practice recommendations to appropriately counsel patients about whether they should be taking low-dose aspirin to prevent cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Shira Klausner (2022) conducted a systematic review in Without cardiovascular disease. Daily low-dose aspirin was evaluated on Death from cardiovascular disease. Daily low-dose aspirin used for primary prevention does not lower the risk of death from cardiovascular disease in adults without a history of cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: